BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15044924)

  • 1. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Lui PC; Lo AW; Scolyer RA; Law BK; Karim R; Lee CS
    Mod Pathol; 2004 Jul; 17(7):827-31. PubMed ID: 15044924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
    Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
    Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
    Djordjevic B; Hanna WM
    Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.
    Tse GM; Lui PC; Vong JS; Lau KM; Putti TC; Karim R; Scolyer RA; Lee CS; Yu AM; Ng DC; Tse AK; Tan PH
    Breast Cancer Res Treat; 2009 Apr; 114(3):441-8. PubMed ID: 18443904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34, CD117, and Ki-67 expression in phyllodes tumor of the breast: an immunohistochemical study of 33 cases.
    Noronha Y; Raza A; Hutchins B; Chase D; Garberoglio C; Chu P; Weiss L; Wang J
    Int J Surg Pathol; 2011 Apr; 19(2):152-8. PubMed ID: 21087983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
    Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
    J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to malignant mammary phyllodes tumors detection.
    Ilić I; Randelović P; Ilić R; Katić V; Milentijević M; Velicković L; Krstić M
    Vojnosanit Pregl; 2009 Apr; 66(4):277-82. PubMed ID: 19441158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
    Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
    Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
    Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
    Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.
    Tse GM; Lui PC; Lee CS; Kung FY; Scolyer RA; Law BK; Lau TS; Karim R; Putti TC
    Hum Pathol; 2004 Sep; 35(9):1053-7. PubMed ID: 15343505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
    Chougule A; Bal A; Das A; Kohli PS; Singh G
    Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
    Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
    Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllodes tumor of the breast: an update.
    Tse GM; Niu Y; Shi HJ
    Breast Cancer; 2010; 17(1):29-34. PubMed ID: 19434472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
    Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
    J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.